MyFinsight
Home
Blog
About
Proceeds from marketable
securities
$113,232K
Proceeds from issuance of
common stock upon...
$17,926K
(1051.32%↑ Y/Y)
Proceeds from issuances
of common stock...
$10,362K
(34.92%↑ Y/Y)
Other
$3,045K
(7526.83%↑ Y/Y)
Net cash provided by
investing activities
$101,473K
(1052.89%↑ Y/Y)
Net cash provided by
(used in) financing...
$23,014K
(1317.12%↑ Y/Y)
Canceled cashflow
$11,759K
Canceled cashflow
$8,319K
Net increase in
cash, cash...
$66,298K
(196.97%↑ Y/Y)
Canceled cashflow
$58,189K
Purchases of property and
equipment
$11,759K
(108.16%↑ Y/Y)
Stock-based compensation
$57,725K
(35.95%↑ Y/Y)
Accounts payable and
accrued liabilities
$44,288K
(1718.71%↑ Y/Y)
Depreciation and
amortization
$9,561K
(-4.79%↓ Y/Y)
Operating lease costs
$8,587K
(0.17%↑ Y/Y)
Interest income received
on marketable...
$1,238K
Other assets, net
-$899K
(-131.70%↓ Y/Y)
Other
-$508K
(-141.64%↓ Y/Y)
Employee taxes paid
related to net share...
$8,319K
(12.10%↑ Y/Y)
Net cash used in
operating activities
-$57,778K
(4.16%↑ Y/Y)
Net effect of
foreign exchange rate...
-$411K
(-143.86%↓ Y/Y)
Canceled cashflow
$122,806K
Revenue
$334,978K
(44.33%↑ Y/Y)
Net loss
-$120,142K
(-20.26%↓ Y/Y)
Canceled cashflow
$334,978K
Inventory, net
$21,612K
(217.59%↑ Y/Y)
Prepaid expenses and
other current assets,...
$16,957K
(303.35%↑ Y/Y)
Operating lease
liabilities
-$9,263K
(-0.02%↓ Y/Y)
Accounts receivable, net
$6,886K
(-51.88%↓ Y/Y)
Deferred revenue
-$4,730K
(-128.35%↓ Y/Y)
Amortization of discount on
marketable securities
$994K
Sales and marketing
expense
$172,360K
(59.84%↑ Y/Y)
Cost of revenue
$111,854K
(42.86%↑ Y/Y)
Research and development
expense
$80,508K
(10.97%↑ Y/Y)
Other segment items
$54,956K
(43.19%↑ Y/Y)
General and
administrative expense
$35,442K
(1.46%↑ Y/Y)
Back
Back
Cash Flow
GuardantHealthMasterLogo_ND_RGBcropped-svg
Guardant Health, Inc. (GH)
GuardantHealthMasterLogo_ND_RGBcropped-svg
Guardant Health, Inc. (GH)
source: myfinsight.com